Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Stefanie Bärthel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5986-4864; OpenAlex author ID A5019267529. Sources: OpenAlex.

Their work

Papers
13 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
60
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 4 papers · 2024: none · 2025: 2 papers · 2026: 4 papers

Papers 13

  1. Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers. Co-author DOI 10.1016/j.xcrm.2025.102546↗
  2. Neutrophil-Driven Trogocytosis in Pancreatic Ductal Adenocarcinoma Liver Metastases Restrains Immunosuppressive Macrophage Polarization and Limits Metastatic P… Co-author DOI 10.1053/j.gastro.2026.04.021↗
  3. Cross-species single-cell atlases chart progression, therapy-driven remodelling and immune evasion in pancreatic cancer Co-author DOI 10.64898/2026.03.19.712924↗
  4. Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model Co-author DOI 10.64898/2026.06.26.734719↗
  5. Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41551-024-01273-9↗
  6. Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time. Co-author DOI 10.1172/jci.insight.169105↗
  7. Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation. First author DOI 10.1038/s41467-023-38171-8↗
  8. Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy. Co-author DOI 10.1038/s43018-023-00526-x↗
  9. Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer. First author DOI 10.1158/2159-8290.cd-22-0876↗
  10. Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. Co-author DOI 10.1172/jci166333↗
  11. Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment. First author DOI 10.1038/s43018-021-00326-1↗
  12. Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer. Co-author DOI 10.3791/64253↗
  13. Blocking the road to de-differentiation: HNF1A/KDM6A complex safeguards epithelial integrity in pancreatic cancer. Co-author DOI 10.15252/embj.2020104759↗

Closest collaborators

The 25 strongest of 60 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dieter Saur · 13 shared papers, 2020–2026 · strength 2.41
  2. Roland Rad · 9 shared papers, 2022–2026 · strength 1.63
  3. Günter Schneider · 7 shared papers, 2020–2026 · strength 1.25
  4. Chiara Falcomatà · 6 shared papers, 2022–2026 · strength 1.15
  5. Daniele Lucarelli · 4 shared papers, 2025–2026 · strength 0.80
  6. Maximilian Reichert · 5 shared papers, 2022–2026 · strength 0.76
  7. Roland Michael Schmid · 4 shared papers, 2023–2026 · strength 0.66
  8. İhsan Ekin Demir · 3 shared papers, 2023–2026 · strength 0.50
  9. Christian Schneeweis · 3 shared papers, 2022–2026 · strength 0.46
  10. H. Carlo Maurer · 2 shared papers, 2025–2026 · strength 0.38
  11. Achim Krüger · 2 shared papers, 2023–2026 · strength 0.33
  12. Kaan Çifcibaşı · 2 shared papers, 2023–2026 · strength 0.33
  13. Carmen Mota Reyes · 2 shared papers, 2023–2026 · strength 0.33
  14. Constantin Schmitt · 2 shared papers, 2022 · strength 0.32
  15. Aristeidis Papargyriou · 2 shared papers, 2025 · strength 0.32
  16. Bernhard Küster · 2 shared papers, 2022–2025 · strength 0.27
  17. Jonathan J. Swietlik · 2 shared papers, 2022–2023 · strength 0.27
  18. Felix Meissner · 2 shared papers, 2022–2023 · strength 0.27
  19. Anna Melissa Schlitter · 1 shared paper, 2026 · strength 0.22
  20. Raphela A. Ranjan · 1 shared paper, 2026 · strength 0.22
  21. Julian Frädrich · 1 shared paper, 2026 · strength 0.21
  22. Jan P. Böttcher · 1 shared paper, 2026 · strength 0.21
  23. Daniel Häußler · 1 shared paper, 2026 · strength 0.21
  24. Francisco X. Real · 1 shared paper, 2026 · strength 0.21
  25. William L. Hwang · 1 shared paper, 2026 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.